在非小细胞肺癌中BRAF突变的治疗策略:一篇综述
Megha Puri1, Kunal Gawri2, Richa Dawar3
1Department of Internal Medicine, Saint Peter's University Hospital, New Brunswick, NJ, United States.
Frontiers in oncology
|August 30, 2023
概括
本综述总结了非小细胞肺癌 (NSCLC) 中的BRAF突变,详细介绍了向疗法,耐药性机制和组合策略. 它强调了改善BRAF突变NSCLC患者治疗结果的进展.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 非小细胞肺癌 (NSCLC) 是癌症死亡的主要原因.
- 像BRAF突变这样的遗传改变是新疗法的关键目标.
- BRAF突变发生在1.5-4%的NSCLC病例中,需要集中研究.
研究的目的:
- 审查BRAF突变类型和NSCLC的可用药物治疗方法.
- 探索对BRAF抑制剂的耐药性机制和克服它们的策略.
- 讨论全面分析和免疫治疗在BRAF突变NSCLC中的作用.
主要方法:
- 关于BRAF突变类型和向治疗的文献综述.
- 对抗机制和克服策略的分析.
- 在BRAF突变的NSCLC中对并发突变和免疫治疗的评估.
主要成果:
- BRAF突变亚型 (V600和非V600) 的总结.
- 对BRAF突变NSCLC的现有和新兴药物疗法的审查.
- 讨论耐药性,组合疗法和免疫疗法.
结论:
- 在NSCLC中,BRAF突变是可操作的目标.
- 了解耐药机制对于有效治疗至关重要.
- 组合疗法和免疫疗法在BRAF突变NSCLC中显示出改善结果的希望.
更多相关视频
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.1K
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
3.0K
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
